Literature DB >> 7116612

Bone studies in patients on prolonged systemic corticosteroid therapy for asthma.

P A Greenberger, R W Hendrix, R Patterson, J S Chmiel.   

Abstract

Cortical thickness of the second metacarpal bone and lumbar spine fractures were determined radiographically in twenty-one caucasian corticosteroid-dependent asthmatics (mean age, 61.2 years; range 47-73 years). The mean number of prednisone years per patient of continuous corticosteroid treatment averages 9.7 (range 5.0-21.5 years), and the mean accumulated dose of prednisone was 46.7 g (range 10.7-160 g). Thirteen of twenty-one (61.9%) patients had cortical thickness between 1 and 2 standard deviations (s.d.) below the age- and sex-specific mean for normals, but only four (19%) patients fell below 2 s.d. Although the study indicated decreased cortical thickness in the prednisone-treated group, in only one (4.8%) patient were vertebral fractures present, an incidence not unexpected in this group. In serious chronic asthma, concern for bone structure should not prohibit the cautious use of appropriate corticosteroid regimens at the lowest possible maintenance dose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7116612     DOI: 10.1111/j.1365-2222.1982.tb02540.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  11 in total

Review 1.  Steroid osteoporosis.

Authors:  I R Reid
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

2.  Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.

Authors:  A Conti; A Sartorio; S Ferrero; S Ferrario; B Ambrosi
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

3.  Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover.

Authors:  B H Jennings; K E Andersson; S A Johansson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Effect of low-dose methylprednisolone on calcium balance and bone composition in rats.

Authors:  A Voulgaris; C Liapi; J Papadopoulos
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

5.  Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.

Authors:  K Olgaard; T Storm; N van Wowern; H Daugaard; M Egfjord; E Lewin; L Brandi
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

6.  Effect of orally administered beclomethasone dipropionate on calcium absorption from the gut in normal subjects.

Authors:  B J Smith; P J Phillips; P R Pannall; H J Cain; W J Leckie
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

7.  Oral glucocorticoid use is associated with an increased risk of fracture.

Authors:  Michael Steinbuch; Thomas E Youket; Stanley Cohen
Journal:  Osteoporos Int       Date:  2004-02-05       Impact factor: 4.507

8.  Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis.

Authors:  E Nordborg; T Hansson; R Jonson; J Szücs; B A Bengtsson
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

9.  Users of low-dose glucocorticoids have increased bone loss rates: a longitudinal study.

Authors:  J K Saito; J W Davis; R D Wasnich; P D Ross
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

10.  Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.

Authors:  V Lo Cascio; J A Kanis; M N Beneton; F Bertoldo; S Adami; G Poggi; M E Zanolin
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.